These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 23500550)

  • 1. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies.
    Esbrit P; Herrera S; Portal-Núñez S; Nogués X; Díez-Pérez A
    Calcif Tissue Int; 2016 Apr; 98(4):359-69. PubMed ID: 26259869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of hPTHrP (1-36) as an anabolic therapeutic agent for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2011 Jan; 21(1):28-32. PubMed ID: 21187591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormones and osteoporosis update. Histological aspects on the action of parathyroid hormone (PTH) and PTH-related peptide (PTHrP) on bone and cartilage].
    Amizuka N; Li M; Tamura M; Oda K
    Clin Calcium; 2009 Jul; 19(7):935-43. PubMed ID: 19567988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
    Goltzman D
    Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
    Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
    J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone downregulates the expression of parathyroid hormone-related protein (PTHrP) in mesenchymal stem cells.
    Ahlström M; Pekkinen M; Lamberg-Allardt C
    Steroids; 2009 Feb; 74(2):277-82. PubMed ID: 19121329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic effects of intermittent PTH on osteoblasts.
    Greenfield EM
    Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes.
    Tenne M; McGuigan F; Jansson L; Gerdhem P; Obrant KJ; Luthman H; Akesson K
    Bone; 2008 Apr; 42(4):719-27. PubMed ID: 18280230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
    Allan EH; Häusler KD; Wei T; Gooi JH; Quinn JM; Crimeen-Irwin B; Pompolo S; Sims NA; Gillespie MT; Onyia JE; Martin TJ
    J Bone Miner Res; 2008 Aug; 23(8):1170-81. PubMed ID: 18627264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
    van der Horst G; Farih-Sips H; Löwik CW; Karperien M
    J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis.
    Polyzos SA; Makras P; Efstathiadou Z; Anastasilakis AD
    Expert Opin Investig Drugs; 2015 Feb; 24(2):145-57. PubMed ID: 25316089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
    Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.
    Augustine M; Horwitz MJ
    Curr Osteoporos Rep; 2013 Dec; 11(4):400-6. PubMed ID: 24078470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
    Bhattacharyya S; Pal S; Chattopadhyay N
    Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
    Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
    J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
    Gensure RC; Gardella TJ; Jüppner H
    Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.